- Home
- VRA vs RGLS Comparison
VRA vs RGLS Comparison
Compare VRA & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- RGLS
- Stock Information
- Founded
- VRA 1982
- RGLS 2007
- Country
- VRA United States
- RGLS United States
- Employees
- VRA N/A
- RGLS N/A
- Industry
- VRA Apparel
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- RGLS Health Care
- Exchange
- VRA Nasdaq
- RGLS Nasdaq
- Market Cap
- VRA 102.9M
- RGLS 102.1M
- IPO Year
- VRA 2010
- RGLS 2012
- Fundamental
- Price
- VRA $3.78
- RGLS $1.24
- Analyst Decision
- VRA Strong Buy
- RGLS Strong Buy
- Analyst Count
- VRA 1
- RGLS 6
- Target Price
- VRA $5.50
- RGLS $10.33
- AVG Volume (30 Days)
- VRA 313.2K
- RGLS 321.7K
- Earning Date
- VRA 03-12-2025
- RGLS 11-07-2024
- Dividend Yield
- VRA N/A
- RGLS N/A
- EPS Growth
- VRA N/A
- RGLS N/A
- EPS
- VRA N/A
- RGLS N/A
- Revenue
- VRA $405,268,000.00
- RGLS N/A
- Revenue This Year
- VRA N/A
- RGLS N/A
- Revenue Next Year
- VRA $4.90
- RGLS N/A
- P/E Ratio
- VRA N/A
- RGLS N/A
- Revenue Growth
- VRA N/A
- RGLS N/A
- 52 Week Low
- VRA $3.27
- RGLS $1.15
- 52 Week High
- VRA $8.32
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- VRA 43.07
- RGLS 33.32
- Support Level
- VRA $3.46
- RGLS $1.17
- Resistance Level
- VRA $4.00
- RGLS $1.40
- Average True Range (ATR)
- VRA 0.21
- RGLS 0.12
- MACD
- VRA 0.07
- RGLS -0.03
- Stochastic Oscillator
- VRA 51.56
- RGLS 14.89
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.